Tormod Nilsen | Cardiac Rehabilitation | Best Researcher Award

 

Best Researcher Award

Tormod Nilsen
The Norwegian School of Sport Science

Tormod Nilsen
Affiliation The Norwegian School of Sport Science
Country Norway
Scopus ID 51864003400
Documents 32
Citations 1,486
h-index 17
Subject Area Cardiac Rehabilitation
Event
Cardiology and Cardiovascular Medicine
ORCID
0000-0002-9380-2808

Tormod Nilsen is a researcher affiliated with The Norwegian School of Sport Science whose academic work focuses on exercise science, cardiovascular health, rehabilitation, and clinical research. His research interests include cardiorespiratory fitness, exercise interventions, cardiovascular risk, and rehabilitation among clinical populations. These research areas connect physical activity with preventive and rehabilitative healthcare and contribute to the broader understanding of cardiovascular outcomes. His scholarly profile is represented by 32 documents, 1,486 citations, and an h-index of 17, according to the supplied researcher information.[1]

Abstract

This article presents a scholarly recognition profile of Tormod Nilsen, a researcher affiliated with The Norwegian School of Sport Science. His research is associated with exercise science, cardiovascular health, cardiac rehabilitation, and clinical research involving physical fitness and exercise interventions. His work contributes to understanding relationships between physical activity, cardiovascular function, rehabilitation, and long-term health outcomes. The supplied research profile records 32 documents, 1,486 citations, and an h-index of 17. His academic activities demonstrate interdisciplinary engagement across exercise physiology, cardiovascular medicine, rehabilitation, and related clinical research. This profile summarizes his research areas, contributions, publications, impact, and suitability for researcher recognition.[1]

Keywords

Cardiac rehabilitation; exercise science; cardiovascular health; cardiorespiratory fitness; cardiovascular medicine; rehabilitation research; exercise intervention; clinical research; physical activity; cancer survivorship.

Introduction

Research in exercise science and cardiac rehabilitation increasingly examines the relationship between physical activity, cardiovascular function, clinical risk, and long-term health. Within this interdisciplinary environment, Tormod Nilsen’s research profile is associated with exercise physiology and cardiovascular rehabilitation. His academic work contributes to research examining how structured exercise can be evaluated in relation to physiological fitness and clinical outcomes.[2]

Research Profile

Nilsen’s research profile is centered on exercise-related cardiovascular and rehabilitation questions. Cardiorespiratory fitness provides an important research measure because it can be examined in relation to physical function, cardiovascular risk, and treatment outcomes. His work also connects exercise research with clinical populations, creating an interdisciplinary research direction involving sports science, rehabilitation, cardiology, and preventive health.[3]

Research Contributions

A significant area of relevance in Nilsen’s research is the evaluation of exercise and cardiorespiratory fitness in clinical populations. Research concerning exercise dose and adherence is also important because accurate reporting of exercise exposure supports reproducibility and interpretation of intervention studies. Such methodological considerations strengthen the evidence base for exercise-based rehabilitation and clinical research.[2]

Publications

The research record associated with Nilsen includes collaborative publications addressing exercise therapy, cardiovascular toxicity, cardiorespiratory fitness, exercise dose, adherence, and rehabilitation. These publications demonstrate engagement with both methodological and clinically oriented research questions. The literature also places exercise within emerging cardiovascular and oncology research frameworks, where rehabilitation and physical fitness are increasingly investigated as components of comprehensive patient care.[3][4][5]

Research Impact

The supplied bibliometric profile reports 32 documents, 1,486 citations, and an h-index of 17. These indicators provide quantitative measures of scholarly visibility, although bibliometric values should always be interpreted according to database coverage, publication history, disciplinary citation patterns, and collaboration practices. The research themes represented in the publication record are relevant to exercise science, cardiovascular rehabilitation, and clinical health research.[1]

Award Suitability

The supplied academic profile provides several factors relevant to consideration for a Best Researcher Award in the field of cardiovascular and rehabilitation research. His reported publication activity, citation record, h-index, and research focus provide measurable indicators for evaluation. The interdisciplinary nature of his work also connects sports science with cardiovascular medicine and rehabilitation, making the profile relevant to an award emphasizing research contributions in these areas.[1]

Conclusion

Tormod Nilsen’s academic profile reflects research activity connecting exercise science, cardiovascular health, and rehabilitation. His research contributions include work concerning exercise interventions, cardiorespiratory fitness, cardiovascular outcomes, exercise methodology, and clinical rehabilitation. The supplied bibliometric information further indicates a measurable publication and citation record. Together, these elements provide an appropriate scholarly basis for consideration within a Best Researcher Award framework.[1]

References

  1. Scopus Author Profile. Tormod Nilsen — Author ID 51864003400.
    https://www.scopus.com/pages/authors/51864003400
  2. Original Article (2015.). Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy.
    https://doi.org/10.1111/sms.12543
  3. Original Article (2012.). The effect of strength training volume on satellite cells, myogenic regulatory factors, and growth factors.
    https://doi.org/10.1111/j.1600-0838.2012.01452.x
  4. ORCID. (n.d.). ORCID record:Tormod Nilsen, ORCID iD0000-0002-9380-2808.
    https://orcid.org/0000-0002-9380-2808
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

 

Emilia D’Elia | Heart Failure | Best Researcher Award

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Cedric Duval | Cardiovascular Researches | Best Researcher Award

Best Researcher Award

Cedric Duval
University of Leeds

Cedric Duval
Affiliation University of Leeds
Country United Kingdom
Scopus ID 55941091300
Documents 43
Citations 1,556
h-index 21
Subject Area Cardiovascular Researches
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-4870-6542

Cedric Duval is presented as a researcher affiliated with the University of Leeds in the United Kingdom, with a stated subject area of cardiovascular research. The supplied academic profile records 43 documents, 1,556 citations, and an h-index of 21. These bibliometric indicators provide quantitative context for evaluating scholarly productivity and research visibility within cardiovascular science. [1]

Abstract

This profile presents Cedric Duval, affiliated with the University of Leeds, as a researcher working within cardiovascular research. The supplied academic indicators report 43 documents, 1,556 citations, and an h-index of 21, providing measurable evidence of publication activity and citation visibility. The profile considers these indicators alongside institutional affiliation, researcher identification information, and the proposed Best Researcher Award context. The assessment emphasizes documented scholarly output, research visibility, and relevance to cardiovascular science. Bibliometric values are presented as supplied and should be interpreted as time-sensitive indicators that may change as databases update records and citations. [1]

Keywords

Cedric Duval, cardiovascular research, cardiovascular medicine, University of Leeds, bibliometrics, scholarly publications, citation impact, h-index, research excellence, Best Researcher Award.

Introduction

Cardiovascular research encompasses scientific investigation into the mechanisms, prevention, diagnosis, treatment, and management of diseases affecting the heart and vascular system. Researchers in this field contribute through experimental studies, clinical investigations, translational research, and interdisciplinary approaches. Academic recognition commonly considers the quality and relevance of research together with evidence of scholarly productivity and influence. [2]

Research Profile

Cedric Duval is identified in the supplied information as being affiliated with the University of Leeds in the United Kingdom. The stated research subject area is cardiovascular research. The associated Scopus Author ID is 55941091300, while the supplied ORCID identifier is 0000-0002-4870-6542. Persistent researcher identifiers help distinguish scholarly records and support accurate attribution of publications across academic information systems. [1] [3]

Research Contributions

The available profile data indicate a sustained body of scholarly output, represented by 43 documents and substantial citation activity. Within cardiovascular research, contributions may be evaluated according to originality, methodological quality, scientific relevance, reproducibility, and potential clinical significance. The supplied bibliometric information provides quantitative context, while publication-level analysis would be required to establish the specific scientific findings and contributions associated with individual works. [1]

Publications

The supplied information attributes 43 documents to the researcher profile. This page does not assign individual article titles, journals, publication dates, or research findings that were not provided in the source information. The Scopus Author ID supplied for this profile can be used to review the indexed publication record, including documents, citations, co-authorship, subject classifications, and related bibliometric information. [1]

Research Impact

The supplied citation count of 1,556 and h-index of 21 indicate measurable visibility within the indexed scholarly record. Citation indicators can assist in describing research influence, although they should be interpreted alongside publication quality, field-specific citation practices, authorship contribution, and publication age. Accordingly, bibliometric measures are most appropriately treated as complementary evidence within a broader academic evaluation rather than as an independent measure of research quality. [1]

Award Suitability

Based on the supplied profile, Cedric Duval demonstrates characteristics relevant to consideration for a Best Researcher Award in cardiovascular research, including documented scholarly output, citation activity, and a stated specialization aligned with cardiovascular science. The reported 43 documents, 1,556 citations, and h-index of 21 provide quantitative evidence for consideration. Final award eligibility and selection should be determined according to the official criteria, verification procedures, and evaluation process established by the organizing body. [1] [4]

Conclusion

Cedric Duval is presented as a cardiovascular research scholar affiliated with the University of Leeds. The supplied bibliometric information records 43 documents, 1,556 citations, and an h-index of 21, providing a concise quantitative profile of scholarly activity. These indicators support consideration within an academic recognition framework, while a complete assessment should incorporate publication quality, research originality, contribution to cardiovascular science, and independently verified evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Cedric Duval, Author ID 55941091300. Scopus.
    https://www.scopus.com/pages/authors/55941091300
  2. Journal article. (2026.) Fibrinogen wags its disordered tail: α chain and thrombosis.
    https://doi.org/10.1182/blood.2026033618
  3. ORCID. (n.d.). ORCID record: Cedric Duval, ORCID iD 0000-0002-4870-6542. ORCID.
    https://orcid.org/0000-0002-4870-6542
  4. Cardiology and Cardiovascular Medicine. (2026.). Academic recognition and award information.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Zhi-Hui Zhu | Cardiovascular Researches | Innovative Research Award

Innovative Research Award

Zhi-Hui Zhu
Zhejiang University, China
Zhi-Hui Zhu
Affiliation Zhejiang University
Country China
Scopus ID 57199280440
Documents 4
Citations 73
h-index 3
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine

The Innovative Research Award recognizes scholarly achievements that have contributed to the advancement of biomedical and life science research. Zhi-Hui Zhu of Zhejiang University has developed a research profile characterized by investigations into liver development, regenerative biology, molecular genetics, and experimental disease modeling. Through studies employing zebrafish and mammalian systems, Zhu has contributed to understanding developmental regulation, tissue regeneration, and cellular lineage mechanisms relevant to human health and disease.[1] The body of work demonstrates interdisciplinary integration of genetics, developmental biology, and translational biomedical research, providing a foundation for future applications in regenerative medicine and cardiovascular-related biological investigations.[2]

Abstract

This article summarizes the scientific contributions of Zhi-Hui Zhu in developmental biology and regenerative research. The documented publications explore liver organogenesis, gene regulation, tissue regeneration, and transgenic model development. Collectively, these studies have contributed to understanding molecular pathways that govern organ formation and repair, providing insights applicable to broader biomedical and cardiovascular research contexts.[3]

Keywords

Developmental biology; Regenerative medicine; Zebrafish genetics; Liver development; Molecular signaling; Tissue regeneration; Functional genomics; Biomedical research.

Introduction

Modern biomedical research increasingly relies on model organisms to uncover mechanisms underlying organ development and disease progression. Zhu’s investigations have focused on genetic and cellular pathways involved in liver biology, utilizing zebrafish and mammalian systems to evaluate developmental processes and regenerative responses. These studies provide mechanistic evidence supporting the role of specific genes and signaling networks in maintaining tissue integrity and recovery following injury.[1][3]

Research Profile

Affiliated with Zhejiang University, Zhi-Hui Zhu has authored and co-authored peer-reviewed publications indexed in major scientific databases. The available metrics indicate four indexed documents, seventy-three citations, and an h-index of three. Research themes encompass developmental genetics, liver biology, transgenic technologies, and regenerative mechanisms, reflecting a consistent commitment to experimentally driven biological inquiry.[1]

Research Contributions

Among Zhu’s notable contributions is the characterization of liver-enriched gene family members essential for normal liver development in zebrafish, expanding knowledge of organogenesis and developmental regulation.[2] Additional investigations examined expression patterns of homologous genes in mammalian systems, providing comparative biological insights.[3] Research on Def haploinsufficiency demonstrated activation of p53-dependent TGFβ signaling during regenerative responses, revealing mechanisms associated with scar formation following partial hepatectomy.[4] Zhu also contributed to transgenic zebrafish methodologies supporting functional genomic analysis of candidate genes involved in tumor pathogenesis.[5]

Publications

  • Chang CQ et al. (2011). Liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish.
  • Zhu ZH et al. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse.
  • Zhu ZH et al. (2014). Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy.
  • Ung CY et al. (2015). Mosaic zebrafish transgenesis for functional genomic analysis of cooperative genes in tumor pathogenesis.
  • Gao C et al. (2018). Hepatocytes in a normal adult liver are derived solely from embryonic hepatocytes.

Research Impact

The research portfolio has contributed valuable evidence regarding developmental pathways, tissue regeneration, and cellular lineage tracing. These findings support broader scientific efforts aimed at understanding disease mechanisms and regenerative therapies. The citation record further indicates continued scholarly engagement with the published findings, particularly in developmental and translational biology disciplines.[1][6]

Award Suitability

Zhu’s record demonstrates sustained contributions to biological research through original investigations, methodological development, and collaborative scientific output. The integration of developmental genetics and regenerative biology aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, particularly where fundamental biological discoveries inform future therapeutic and translational applications.[5]

Conclusion

Zhi-Hui Zhu’s scholarly contributions reflect a focused research trajectory in developmental and regenerative biology. Through investigations involving gene regulation, organ development, and cellular regeneration, the researcher has advanced scientific understanding of biological processes relevant to health and disease. The documented body of work provides a credible basis for recognition through an academic research award program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zhi-Hui Zhu, Author ID 57199280440. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57199280440
  2. Chang CQ, Hu MJ, Zhu ZH, et al. (2011). Liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0022910
  3. Zhu ZH, Hu MJ, Chang CQ, Peng JR. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse. Hereditas.
  4. Zhu ZH, Chen J, Xiong JW, Peng JR. (2014). Haploinsufficiency of Def Activates p53-Dependent TGFβ Signalling and Causes Scar Formation after Partial Hepatectomy. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0096576
  5. Ung CY, Guo F, Zhang X, Zhu Z, Zhu S. (2015). Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis. Journal of Visualized Experiments.
    https://doi.org/10.3791/52567
  6. Gao C, Zhu Z, Gao Y, et al. (2018). Hepatocytes in a Normal Adult Liver Are Derived Solely from the Embryonic Hepatocytes. Journal of Genetics and Genomics.
    https://doi.org/10.1016/j.jgg.2017.12.003

Sandra Celina Fernandes Fonseca | Cardiology | Innovative Research Award

Innovative Research Award

Sandra Celina Fernandes Fonseca
University of Trás-os-Montes and Alto Douro
Sandra Celina Fernandes Fonseca
Affiliation University of Trás-os-Montes and Alto Douro
Country Portugal
Scopus ID 57191525441
Documents 23
Citations 85
h-index 5
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9468-7269

The Innovative Research Award recognizes sustained scholarly contributions that advance evidence-based understanding in cardiovascular and health sciences. Sandra Celina Fernandes Fonseca, affiliated with the University of Trás-os-Montes and Alto Douro, has developed an interdisciplinary research portfolio examining exercise physiology, cardiovascular responses, athlete well-being, and health promotion across diverse populations. Her publication record demonstrates engagement with clinically relevant topics at the intersection of cardiology, physical activity, and preventive medicine.[1]

Abstract

Fonseca’s research addresses the physiological and behavioral determinants of cardiovascular health, with particular emphasis on exercise responses, athlete health, and lifestyle-related risk factors. Her work integrates observational and applied methodologies to evaluate how physical activity, motivation, sleep, and substance use influence cardiovascular outcomes and performance indicators.[2]

Keywords

Cardiology; exercise physiology; cardiovascular medicine; athlete health; physical activity; preventive health; sleep quality; sports science.

Introduction

Contemporary cardiovascular research increasingly recognizes the importance of behavioral and environmental determinants of health. Fonseca’s investigations contribute to this perspective by examining how exercise intensity, perceived exertion, nutrition, and psychosocial variables affect cardiovascular adaptation and well-being across athletic and general populations.[3]

Research Profile

According to indexed author records, Fonseca has authored or co-authored 23 Scopus-indexed documents with 85 citations and an h-index of 5. Her scholarship spans cardiology, sports medicine, public health, and kinesiology, reflecting a multidisciplinary approach to cardiovascular prevention and health promotion.[1]

Research Contributions

  • Assessment of cardiovascular responses to exercise under varying behavioral conditions, including alcohol consumption.
  • Investigation of sleep quality, motivation, and mental health among Paralympic athletes.
  • Evaluation of caffeine-related effects on glycaemia and blood pressure in combat sports participants.
  • Analysis of physical activity patterns and self-rated health during the COVID-19 pandemic.

Publications

Selected publications include studies in Nutrients, Sports, Turkish Journal of Kinesiology, and O Mundo da Saúde. Notable recent works examine cardiovascular responses to exercise and alcohol interaction and predictive factors associated with athlete mental health during social isolation.[4]

Research Impact

The practical implications of Fonseca’s work extend to exercise prescription, athlete monitoring, and preventive cardiovascular care. By integrating physiological measures with behavioral indicators, her studies support more comprehensive approaches to health promotion and performance optimization.[5]

Award Suitability

Fonseca’s multidisciplinary output aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. Her emphasis on translational research, preventive health strategies, and evidence-informed interventions demonstrates relevance to current priorities in cardiovascular science and population health.[6]

Conclusion

Sandra Celina Fernandes Fonseca has established a coherent research agenda centered on exercise-related cardiovascular outcomes and health behavior. Her scholarly contributions provide meaningful insights for clinicians, researchers, and public health practitioners seeking to improve cardiovascular well-being through lifestyle-based interventions.

References

  1. Elsevier. (n.d.). Scopus author details: Sandra Celina Fernandes Fonseca, Author ID 57191525441. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57191525441
  2. Fonseca, S. C. F., et al. (2026). Cardiovascular Response to Exercise with and Without Alcohol Consumption. Nutrients.
    DOI: https://doi.org/10.3390/nu18091407
  3. Fonseca, S. C. F., et al. (2026). Predictive Factors of Mental Health in Athletes from the Paralympic Preparation Program During Social Isolation. Sports.
    DOI: https://doi.org/10.3390/sports14040160
  4. Fonseca, S. C. F., et al. (2025). Effects of caffeine on glycaemia and blood pressure in women practising Muay Thai. Turkish Journal of Kinesiology.
    DOI: https://doi.org/10.31459/turkjkin.1704368
  5. Fonseca, S. C. F., et al. (2025). Physical activity practice and negative self-rated health among university students during COVID-19. O Mundo da Saúde.
    DOI: https://doi.org/10.15343/0104-7809.202549e17082025I
  6. Pencis. (n.d.). International Research Awards on Cardiology & Cardiovascular Medicine.
    cardiology-conferences.pencis.com

Yishan Zhou | Cardiology | Most Reader’s Article Award

Ms. Yishan Zhou | Cardiology | Most Reader's Article Award

The Seventh Clinical College of Guangzhou University of Chinese Medicine | China

Ms. Zhou Yishan is a dedicated researcher in Chinese Internal Medicine whose academic and professional journey reflects consistent excellence and a strong commitment to advancing integrative medical practice. She earned her Bachelor of Medicine in Clinical Medicine (Integrated Chinese and Western Medicine) from Guangzhou Medical University, followed by a Master of Medicine in Chinese Internal Medicine (Nephrology) from Guangzhou University of Chinese Medicine. During her postgraduate studies, she served as a core project member in the Sanming Project of Medicine in Shenzhen, contributing to research initiatives focused on clinical nephrology. She also played a key role in the Baoan District Association of Chinese Medicine Promotion Project, working on the clinical evaluation of the Yiqi Huoxue Fumigation-Wash formula for preventing early failure of autogenous arteriovenous fistulas, demonstrating her commitment to improving patient outcomes through evidence-based traditional therapies. Earlier in her academic career, she served as a Research Assistant at the National Center for Respiratory Medicine, supporting Professor Sun’s team through data collection, literature reviews, and preparation of research materials, which strengthened her multidisciplinary foundation. Her achievements have been recognized through honors such as Outstanding Graduate and University Merit Student, along with multiple First-Class and Second-Class Scholarships. With 2 published documents, 11 citations, and an h-index of 1, Ms. Zhou continues to build a promising research profile grounded in rigorous clinical investigation and integrative medical innovation.

Profile: Scopus

Featured Publications

Zhou, Y., Zou, Y., Cao, Y., et al. (2025). The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES. Frontiers in Endocrinology, 16, 1545968.

Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024). Association between oxidative balance score in adults with and without chronic kidney disease: 2011–2028 NHANES. Frontiers in Nutrition, 11, 1374719.

Zhou, Y., et al. (2025). Clinical observation on Yiqi Huoxue Fumigation-Wash Formula for preventing early failure of autogenous arteriovenous fistula. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(08), 114–120, 127.

Zhou, Y., et al. (2024). Exploration on the clinical application of Ephedrae Herba in stimulating Yang Qi. Journal of Guangzhou University of Traditional Chinese Medicine, 41(01), 234–239.

Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Dr. Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Neighborhood Physical Therapy PC | United States

Dr. Maheshkumar Baladaniya, PT, MS, DPT, is a highly accomplished and licensed Physical Therapist recognized for his extensive expertise in clinical rehabilitation, healthcare management, and research. Currently serving as Clinical Director at Neighborhood PT PC in New City, NY, he brings a decade of progressive experience in patient care, program leadership, and interdisciplinary coordination. His clinical focus spans pediatric, geriatric, neuro, orthopedic, sports, and cardiopulmonary rehabilitation, where he integrates evidence-based therapeutic approaches to enhance functional recovery and quality of life. Dr. Baladaniya has successfully developed and implemented innovative rehabilitation programs, supervised multidisciplinary teams, and contributed to quality improvement initiatives across clinical settings. He holds a Doctor of Physical Therapy from the University of Montana, USA, a Master of Science in Health Informatics from the American College of Commerce and Technology, VA, and dual Master’s degrees in Physiotherapy (Sports and Neurology) from the National Institute of Medical Science, Jaipur, India, along with a Bachelor’s degree in Physiotherapy from Acharya Institute of Health Sciences, Bangalore, India. In addition to his clinical and leadership roles, Dr. Baladaniya is an active researcher with 24 published documents, 74 citations, and an h-index of 4, underscoring his academic impact and commitment to advancing rehabilitation science. His professional journey reflects dedication to excellence in patient-centered care, clinical innovation, and lifelong learning in physical therapy.

Profiles: Orcid | Google Scholar

Featured Publications

Baladaniya, M. (2024). Epidemiological study on developmental coordination disorder in school-going children. Journal of Pediatrics Research Reviews & Reports.

Baldania, S., & Baladaniya, M. (2024). Heart and lung dysfunction prevention through rehabilitation and physical therapy education: A comprehensive overview. Journal of Cardiology Research Review & Reports.

Baladaniya, M., & Baldania, S. (2024). Intersectionality in neurodevelopmental disorders: A literature review on co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder – Examining therapeutic approaches and interventions. International Journal of Health Sciences.

Baladaniya, M., & Gulrandhe, P. (2024). Shoulder and elbow synergy for lateral epicondylalgia management: A case report. Journal of Clinical and Diagnostic Research.

Baladaniya, M., & Korat, A. S. (2024). The impact of digital technology use on child development: A comprehensive literature review. Journal of Pediatrics Research Reviews & Reports.

Yiqun Shi | Cardiology | Best Researcher Award 2025

Dr. Yiqun Shi | Cardiology | Best Researcher Award

Beijing Friendship Hospital | Capital Medical University | China

Author Profile

Orcid

Early Academic Pursuits

Dr. Yiqun Shi began his academic journey at the Health Science Center of Peking University, where he pursued Clinical Medicine. His early training laid a strong foundation in medical sciences, combining theoretical knowledge with practical exposure. He showcased exceptional dedication and consistently demonstrated a broad vision that extended beyond traditional clinical practices. This formative stage not only strengthened his medical competence but also nurtured his curiosity toward innovative approaches in cardiovascular research.

Professional Endeavors

Building upon his undergraduate foundation, Dr. Shi advanced his medical career at Peking University People’s Hospital, where he successfully completed his doctoral training in Clinical Medicine. His professional path was marked by perseverance, rigorous research, and continuous skill development. He actively engaged in clinical cardiology and emergency medicine, balancing practical medical responsibilities with research pursuits. His dedication to bridging patient care with scientific inquiry has been a defining characteristic of his career trajectory.

Contributions And Research Focus

Dr. Shi’s research primarily focuses on myocardial bridging, a specialized area within cardiovascular medicine. His investigations explore the structural and functional impact of myocardial bridging on coronary anatomy and hemodynamics. Alongside this, he developed expertise in non-invasive hemodynamic assessment methods, aligning his work with contemporary technological advancements in cardiovascular diagnostics. Additionally, his independent study of artificial intelligence and its application to clinical research allowed him to contribute to the development of innovative deep learning models for cardiovascular assessment.

Impact And Influence

The significance of Dr. Shi’s research lies in its ability to inform and refine clinical practices in cardiology. By enhancing the understanding of coronary myocardial bridging, his contributions provide valuable insights into diagnostic approaches and patient management strategies. His work bridges clinical application with technology-driven solutions, thereby influencing not only cardiologists but also the wider medical research community. His ability to merge traditional clinical expertise with modern technological tools places him at the forefront of emerging trends in cardiovascular medicine.

Academic Cites

Dr. Shi has published widely in peer-reviewed international journals, with his work receiving citations from academic peers and fellow researchers in cardiology and emergency medicine. His publications highlight both clinical case insights and advanced methodological research, reflecting the interdisciplinary nature of his academic endeavors. The growing recognition of his work demonstrates his increasing influence in shaping discussions around myocardial bridging and cardiovascular diagnostics.

Legacy And Future Contributions

Looking ahead, Dr. Shi is committed to advancing innovative, patient-centered approaches in cardiology. His legacy lies in combining clinical medicine with cutting-edge technologies such as artificial intelligence and non-invasive assessment techniques. By continuing to investigate myocardial bridging and related cardiovascular conditions, he aims to create pathways that integrate early detection, precision diagnostics, and improved patient outcomes. His contributions are likely to inspire future researchers, strengthening the bridge between traditional medicine and evolving scientific innovations.

Conclusion

Dr. Yiqun Shi represents the embodiment of academic excellence, professional dedication, and research-driven innovation in the field of cardiology. His career reflects a consistent effort to integrate clinical practice with technological progress, addressing pressing challenges in cardiovascular medicine. Through his pioneering work on myocardial bridging and his commitment to harnessing artificial intelligence, Dr. Shi stands as a promising contributor to both present and future advancements in global medical research.

Notable Publication

"Impact of Myocardial Bridging on Hemodynamics Evaluated by Coronary Angiography-Derived Fractional Flow Reserve"

Authors: Yiqun Shi, Jian Liu
Journal:
The American Journal of Cardiology
Year:
2025

Heng Zhang | Cardiology | Best Researcher Award

Dr. Heng Zhang | Cardiology | Best Researcher Award

Fuwai Hospital, National Center for Cardiovascular Diseases | China

Author Profile

Scopus

Orcid ID

HENG ZHANG, M.D., PH.D. 🩺🫀

Dr. Heng Zhang is a distinguished medical professional specializing in cardiovascular surgery, with substantial contributions to the field of cardiovascular disease research, clinical practice, and health innovation. Holding a dual degree in medicine (M.D.) and a doctorate in philosophy (Ph.D.), Dr. Zhang’s academic and professional endeavors continue to shape the landscape of modern cardiovascular surgery, offering valuable insights into risk prediction, coronary revascularization, and the optimization of treatment strategies for cardiovascular diseases. His current role as an Associate Chief Physician at Fuwai Hospital, National Clinical Research Center of Cardiovascular Diseases, further cements his impact on the advancement of medical science.

EARLY ACADEMIC PURSUITS 🎓

Dr. Heng Zhang's academic journey began with an M.D. degree from Tianjin Medical University, where he graduated in 2010. During his studies, Dr. Zhang displayed a keen interest in cardiovascular health, which led him to pursue a Ph.D. in Cardiovascular Disease from Peking Union Medical College in 2015. Throughout his academic path, he also participated in key research exchanges, including a Visiting Scholar program in the USA at Duke Clinical Research Institute, further broadening his expertise in cardiovascular outcomes research and clinical performance measures.

PROFESSIONAL ENDEAVORS 👨‍⚕️🏥

Dr. Zhang’s clinical training began in 2009 with an internship at Nankai Hospital and continued through various stages of residency, including Peking Union Medical College Hospital and Fuwai Hospital. By 2015, he began specializing in cardiovascular surgery, eventually becoming an Attending Physician at Fuwai Hospital in 2019. His extensive clinical exposure includes pediatric and adult cardiac surgery, where he gained invaluable experience in treating complex heart conditions and improving patient outcomes through innovative surgical techniques.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY🔬💡

Dr. Zhang’s research has primarily focused on cardiovascular surgery registry, coronary revascularization risk prediction, and optimizing diagnostic and treatment strategies for cardiovascular conditions. He is deeply engaged in cardiovascular outcomes research, with particular attention to improving clinical performance measures and treatment protocols for heart diseases.

As the principal investigator and host of multiple high-impact research projects, Dr. Zhang has led groundbreaking studies such as evaluating the efficacy and safety of RN medications in preventing myocardial injury caused by ischemia-reperfusion and examining macrophage subtypes in coronary atherosclerosis. He has also significantly contributed to understanding valve replacement surgery and the long-term effects of heart valve interventions.

IMPACT AND INFLUENCE 🌍💪

Dr. Zhang's contributions to cardiovascular medicine have left a profound mark on clinical practice and research. Through his involvement in various research grants, including National Key Research and Development Plans of China and the Natural Science Foundation of China, Dr. Zhang has been pivotal in advancing both the theoretical and practical aspects of cardiovascular disease treatment and prevention. His work has also led to a shift in how cardiovascular surgeries are approached, particularly regarding patient-specific interventions in coronary artery malformation and atrial fibrillation.

His research projects have earned him several prestigious accolades, such as the Outstanding Reviewer for the Chinese Clinical Journal of Thoracic and Cardiovascular Surgery and the American Heart Association Travel Stipend Award. Dr. Zhang’s clinical and academic contributions are shaping future medical protocols, paving the way for a more personalized approach to heart disease treatment.

ACADEMIC CITES & HONORS 🏅📚

Dr. Zhang’s academic excellence is reflected not only in his research citations but also in the numerous honors and scholarships he has received. These include multiple first prizes for Young Investigator Awards, outstanding doctoral dissertations, and recognitions for clinical excellence. His impressive list of awards, including the Beijing Science and Technology Award (2016) and the Outstanding Doctoral Dissertation from Peking Union Medical College (2016), highlights his leadership and commitment to medical innovation.

LEGACY AND FUTURE CONTRIBUTIONS 🔮🏅

Dr. Zhang’s legacy lies in his consistent drive to innovate and advance cardiovascular surgery. His work with various research institutions and medical centers has laid a robust foundation for the continued improvement of heart disease diagnosis and treatment. As a principal investigator for several key projects and his role on editorial boards such as the Journal of American Heart Association, Dr. Zhang is poised to influence future cardiovascular research and practice for years to come.

Looking ahead, his research into heart valve replacement and atrial fibrillation is expected to lead to new clinical strategies that will enhance patient care globally. His future contributions are expected to redefine approaches to cardiovascular health, with an emphasis on personalized medicine and novel surgical techniques.

FINAL THOUGHTS 🧠💖

Dr. Heng Zhang is a leading figure in cardiovascular medicine, combining clinical expertise with cutting-edge research to make significant advancements in heart disease treatment. His future is one of continued excellence and innovation, as he works tirelessly to shape the future of cardiovascular care, improving the lives of patients worldwide.

NOTABLE PUBLICATIONS 📑

"Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study

  • Authors: Z., Li, Zhongchen , C., Yu, Chunyu , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
  • Journal: Cardiovascular Diabetology
  • Year: 2025

"Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study

  • Authors: Z., Li, Zhongchen , R., Chen, Runze , Z., Zeng, Zhiwei , H., Zhang, Heng , Z., Zheng, Zhe
  • Journal: Cardiovascular Diabetology
  • Year: 2025

"Clinical Outcomes of Surgical Revascularization Strategies Guided by Quantitative Flow Ratio in Primary Noncoronary Cardiac Surgery

  • Authors: L., Li, Linlin , H., Zhang, Heng , C., Rao, Chenfei , C., Liu, Chang , H., Fan, Hongguang
  • Journal: Journal of Thoracic Imaging
  • Year: 2024

"Association of carotid duplex ultrasonography screening with stroke and mortality among patients undergoing coronary artery bypass grafting

  • Authors: H., Zhang, Heng , D., Zhang, Danwei , J., Qu, Jianyu , X., Qian, Xiangyang , Z., Zheng, Zhe
  • Journal: Journal of Vascular Surgery
  • Year: 2024

"Impact of High Lipoprotein(a) on Long-Term Survival Following Coronary Artery Bypass Grafting

  • Authors: S., Yuan, Shuo , F., Li, Fangzhou , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
  • Journal: Journal of the American Heart Association
  • Year: 2024